InvestorsHub Logo
Followers 32
Posts 2803
Boards Moderated 3
Alias Born 10/24/2015

Re: NY1972 post# 122

Friday, 12/18/2020 3:16:24 PM

Friday, December 18, 2020 3:16:24 PM

Post# of 247
Unlikely, as most aren't ''stem like.'' Now during manufacturing of the ADP-A2M4CD8 product they add an ATKi. This increases the percentage of CD8+ T-cells of the naive and central memory phenotype. It also improves antigen-specific killing and effector functions.

The first registration directed trial (in gastroesophageal) will be underway next year.

Exploring the use of other small molecule inhibitors could help as well https://www.sciencedirect.com/science/article/abs/pii/S1535610820302543
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADAP News